Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.79975
+0.0077 (0.98%)
Aug 20, 2026, 2:57 PM EDT - Market open
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $68.41 million as of August 20, 2026. Its market cap has increased by 166.85% in one year.
Market Cap
68.41M
Enterprise Value
27.76M
1-Year Change
166.85%
Ranking
Category
Stock Price
$0.80
ChartMarket Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $68.41M, a decrease of -56.94%. That is a compound annual growth rate of -8.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 68.41M | 124.35% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 74.55M |
| Annovis Bio | 74.02M |
| Telomir Pharmaceuticals | 72.90M |
| LeonaBio | 72.42M |
| iBio, Inc. | 72.03M |
| XBiotech | 70.43M |
| Cardiff Oncology | 70.35M |
| Cingulate | 70.17M |